Sheldon Kaplan “always wanted to be an engineer and to go to Northeastern,” recalls his son, Michael. Kaplan lived out those dreams, and the world-famous EpiPen he invented has saved countless lives. Kaplan, who died in 2009, was inducted this year into the National Inventors Hall of Fame. Here’s his story.
A firestorm erupted this week in response to the pharmaceutical company Mylan’s sharp increase in the price of its EpiPen, a life-saving treatment for severe allergic reactions. The company quickly backtracked, announcing a rebate plan. Here, three Northeastern faculty members—pharmacist Tayla Rose, healthcare finance expert Steven Pizer, and health policy researcher Gary Young—explain the clinical, economic, and policy implications of the controversy.